Latest stories on EDIT
CRISPR Therapeutics vs. Editas Medicine: Which Gene Editing Stock Is a Better Buy in 2026?
Yahoo Finance53 · neutralproduct/pr
Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference | EDIT Stock News
StockTitan50 · neutralgeneral
Editas Medicine: Resetting Pipeline Just To Be Second To Market Again
Seeking Alpha47 · neutralproduct/pr
Editas Medicine Raises Capital Through Public Equity Offering
TipRanks58 · neutralgeneral
Editas Medicine Announces Pricing of Up to $319.4 Million Public Offering | EDIT Stock News
StockTitan47 · neutralgeneral
Editas Medicine stock dips on proposed equity offering
Seeking Alpha33 · bearishgeneral
Editas Showcases Promising EDIT-401 Data for Hyperlipidemia
TipRanks61 · neutralproduct/pr
Editas Medicine Announces Proposed Public Offering | EDIT Stock News
StockTitan47 · neutralgeneral